179 related articles for article (PubMed ID: 27659389)
21. Sex Differences in Renal Outcomes After Medical Treatment for Bilateral Primary Aldosteronism.
Nakamaru R; Yamamoto K; Akasaka H; Rakugi H; Kurihara I; Yoneda T; Ichijo T; Katabami T; Tsuiki M; Wada N; Yamada T; Kobayashi H; Tamura K; Ogawa Y; Kawashima J; Inagaki N; Fujita M; Oki K; Kamemura K; Tanabe A; Naruse M;
Hypertension; 2021 Feb; 77(2):537-545. PubMed ID: 33356395
[TBL] [Abstract][Full Text] [Related]
22. Association of Dip in eGFR With Clinical Outcomes in Unilateral Primary Aldosteronism Patients After Adrenalectomy.
Chen JY; Huang KH; Lin YH; Chueh JS; Wang HY; Wu VC
J Clin Endocrinol Metab; 2024 Feb; 109(3):e965-e974. PubMed ID: 38051943
[TBL] [Abstract][Full Text] [Related]
23. Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism.
Matsuda Y; Kawate H; Matsuzaki C; Sakamoto R; Shibue K; Ohnaka K; Anzai K; Nomura M; Takayanagi R
Endocr J; 2016; 63(3):249-55. PubMed ID: 26727302
[TBL] [Abstract][Full Text] [Related]
24. Changes in Glucose Metabolism after Adrenalectomy or Treatment with a Mineralocorticoid Receptor Antagonist for Primary Aldosteronism.
Lin YF; Peng KY; Chang CH; Hu YH; Wu VC; Chung SD;
Endocrinol Metab (Seoul); 2020 Dec; 35(4):838-846. PubMed ID: 33261310
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biochemical outcomes after adrenalectomy and medical treatment in patients with unilateral primary aldosteronism.
Katabami T; Fukuda H; Tsukiyama H; Tanaka Y; Takeda Y; Kurihara I; Ito H; Tsuiki M; Ichijo T; Wada N; Shibayama Y; Yoshimoto T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Takahashi K; Fujita M; Watanabe M; Matsuda Y; Kobayashi H; Shibata H; Kamemura K; Otsuki M; Fujii Y; Yamamoto K; Ogo A; Yanase T; Suzuki T; Naruse M;
J Hypertens; 2019 Jul; 37(7):1513-1520. PubMed ID: 31145370
[TBL] [Abstract][Full Text] [Related]
26. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
Catena C; Colussi GL; Marzano L; Sechi LA
Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
[TBL] [Abstract][Full Text] [Related]
27. Relative glomerular hyperfiltration in primary aldosteronism.
Ribstein J; Du Cailar G; Fesler P; Mimran A
J Am Soc Nephrol; 2005 May; 16(5):1320-5. PubMed ID: 15800124
[TBL] [Abstract][Full Text] [Related]
28. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
29. Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.
Kaga M; Utsumi T; Tanaka T; Kono T; Nagano H; Kawamura K; Kamiya N; Imamoto T; Nihei N; Naya Y; Suzuki H; Ichikawa T
World J Surg; 2015 Dec; 39(12):2935-40. PubMed ID: 26296835
[TBL] [Abstract][Full Text] [Related]
30. Intrarenal hemodynamics in primary aldosteronism before and after treatment.
Sechi LA; Di Fabio A; Bazzocchi M; Uzzau A; Catena C
J Clin Endocrinol Metab; 2009 Apr; 94(4):1191-7. PubMed ID: 19141581
[TBL] [Abstract][Full Text] [Related]
31. Predictors of malignancy in primary aldosteronism.
Agha A; Hornung M; Iesalnieks I; Schreyer A; Jung EM; Haneya A; Schlitt HJ
Langenbecks Arch Surg; 2014 Jan; 399(1):93-8. PubMed ID: 24048685
[TBL] [Abstract][Full Text] [Related]
32. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment.
Wu VC; Kuo CC; Wang SM; Liu KL; Huang KH; Lin YH; Chu TS; Chang HW; Lin CY; Tsai CT; Lin LY; Chueh SC; Kao TW; Chen YM; Chiang WC; Tsai TJ; Ho YL; Lin SL; Wang WJ; Wu KD;
J Hypertens; 2011 Sep; 29(9):1778-86. PubMed ID: 21738054
[TBL] [Abstract][Full Text] [Related]
33. Analysis of postoperative biochemical values and clinical outcomes after adrenalectomy for primary aldosteronism.
Swearingen AJ; Kahramangil B; Monteiro R; Krishnamurthy V; Jin J; Shin J; Siperstein A; Berber E
Surgery; 2018 Apr; 163(4):807-810. PubMed ID: 29249599
[TBL] [Abstract][Full Text] [Related]
34. Long-term effect of specific treatment of primary aldosteronism on carotid intima-media thickness.
Holaj R; Rosa J; Zelinka T; Štrauch B; Petrák O; Indra T; Šomlóová Z; Michalský D; Novák K; Wichterle D; Widimský J
J Hypertens; 2015 Apr; 33(4):874-82; discussion 882. PubMed ID: 25490707
[TBL] [Abstract][Full Text] [Related]
35. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
[TBL] [Abstract][Full Text] [Related]
36. Usefulness of Alternative Therapy with Hydrocortisone in the Postoperative Management of Severe Primary Aldosteronism.
Asakawa M; Takagi N; Hamada D; Yamasaki Y; Takaku Y; Kawada M; Murata T; Katsuta H
Intern Med; 2023 Oct; 62(20):2981-2988. PubMed ID: 36858518
[TBL] [Abstract][Full Text] [Related]
37. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism.
Watanabe D; Morimoto S; Morishima N; Ichihara A
Endocrine; 2024 Apr; 84(1):245-252. PubMed ID: 38087188
[TBL] [Abstract][Full Text] [Related]
38. Impact of primary aldosteronism on renal function in patients with type 2 diabetes.
Katsuragawa S; Tsurutani Y; Takiguchi T; Saito J; Nishikawa T
J Diabetes Investig; 2021 Feb; 12(2):217-225. PubMed ID: 32583599
[TBL] [Abstract][Full Text] [Related]
39. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
40. Aldosterone response to adrenocorticotrophin and furosemide in primary aldosteronism after prolonged spironolactone treatment.
Yagi A; Ichikawa S; Sakamaki T; Ono Z; Sato K; Nakamura T; Sakamoto H; Murata K
Eur J Endocrinol; 1994 Sep; 131(3):215-20. PubMed ID: 7921203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
